Results

eNauka >  Rezultati >  Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2)
Naziv: Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2)
Autori: Pillai, Rathi N; Fennell, Dean; Kovcin, Vladimir N; Ciuleanu, Tudor E; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Perin, Branislav M; Yalcin, Ilker; Teofilovici, Florentina;
Vukovic, Vojo M; Ramalingam, Suresh S;
Godina: 2017
Publikacija: JOURNAL OF THORACIC ONCOLOGY
ISSN: 1556-0864 Journal of Thoracic Oncology Pretraži identifikator
Tip rezultata: Konferencijski rad
Kolacija: vol. 12 br. 1 str. S7-S8
DOI: 10.1016/j.jtho.2016.11.009
WoS-ID: 000413055800007
URI: https://enauka.gov.rs/handle/123456789/817290
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

12
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.